相关实验视频

Updated: Sep 13, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

在SOX10缺陷黑色素瘤中转质氨酶-2的升高促进瘤发作,并减少内CD4+T细胞

Signe Caksa¹, Timothy J Purwin², Dan A Erkes²

¹Thomas Jefferson University, Philadelphia, United States.

Cancer research

|July 31, 2025

概括

黑色素瘤中SOX10的损失通过上调TGM2 (转胺酶2) 促进了侵入性状态和免疫逃避. 过度表达TGM2会产生免疫抑制的瘤微环境,阻碍免疫治疗的有效性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

黑色素瘤的异质性推动了治疗耐药性和免疫逃避.
SOX10转录因子的损失会导致转换为一种侵入性,耐药的表型.
缺乏SOX10的黑色素瘤细胞可以逃避免疫疗法,需要对免疫逃避机制进行研究.

研究的目的:

为了确定调节黑色素瘤中SOX10损失下游免疫逃避的因素.
研究TGM2在SOX10缺陷黑色素瘤中的作用及其对瘤微环境的影响.

主要方法:

对缺乏SOX10的黑色素瘤细胞系和患者样本的分析.
评估TGM2表达及其由BET蛋白调节.
在免疫能力和免疫缺陷小鼠模型中评估TGM2对瘤生长的影响.
在TGM2过度表达的瘤中研究CD4+T细胞群.

主要成果:

缺乏SOX10的黑色素瘤细胞显示TGM2水平升高.
TGM2上调与BET蛋白抑制有关,并由它逆转.
过度表达TGM2促进了免疫能力强的小鼠的瘤发病,这些小鼠依赖CD4+T细胞.
过度表达TGM2与减少的内CD4+T细胞相关.

结论:

在黑色素瘤中,SOX10负面调节TGM2表达.
通过培养免疫抑制微环境,TGM2促进黑色素瘤瘤的生长.
准TGM2可能是克服黑色素瘤免疫疗法耐药性的策略.

更多相关视频

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...